NYSE - Delayed Quote USD

Nevro Corp. (NVRO)

9.79 -0.72 (-6.85%)
At close: May 10 at 4:00 PM EDT
10.05 +0.26 (+2.66%)
After hours: May 10 at 6:40 PM EDT
Loading Chart for NVRO
DELL
  • Previous Close 10.51
  • Open 10.59
  • Bid 9.28 x 800
  • Ask 10.31 x 1100
  • Day's Range 9.76 - 10.74
  • 52 Week Range 9.76 - 28.89
  • Volume 585,022
  • Avg. Volume 513,320
  • Market Cap (intraday) 359.573M
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) --
  • EPS (TTM) -2.28
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.37

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

nevro.com

1,215

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NVRO

Performance Overview: NVRO

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVRO
54.51%
S&P 500
9.49%

1-Year Return

NVRO
64.53%
S&P 500
26.79%

3-Year Return

NVRO
93.73%
S&P 500
23.39%

5-Year Return

NVRO
84.40%
S&P 500
81.93%

Compare To: NVRO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NVRO

Valuation Measures

Annual
As of 5/10/2024
  • Market Cap

    359.57M

  • Enterprise Value

    295.99M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    1.29

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.17%

  • Return on Assets (ttm)

    -10.18%

  • Return on Equity (ttm)

    -28.49%

  • Revenue (ttm)

    430.75M

  • Net Income Avi to Common (ttm)

    -82.59M

  • Diluted EPS (ttm)

    -2.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    281.48M

  • Total Debt/Equity (mrq)

    80.33%

  • Levered Free Cash Flow (ttm)

    -31.56M

Research Analysis: NVRO

Company Insights: NVRO

Research Reports: NVRO

People Also Watch